2025 Speakers

Adam Garske

Director - Protein Engineering

Mammoth Biosciences

Alexandria Petrusich

Vice President - Clinical Science

Prime Medicine

Anna Pugh

scientist

Tune Therapeutics

Anubhav Arora

Director - Chemistry, Manufacturing, and Controls

Apellis Pharmaceuticals

Ben Kleinstiver

Associate Professor Mass General Hospital

Harvard Medical School

Brad Ringeisen

Executive Director

Innovative Genomics Initiative

Carlo Zambonelli

Director, LNP Analytical Development

CRISPR Therapeutics

Chris Brown

Vice President - Discovery

Metagenomi

Dan Hart

Head of Technology Development

Epicrispr Biotechnologies

Eric Kmiec

Chief Executive Officer

CorriXR Therapeutics

Greg Newby

Assistant Professor

Johns Hopkins University

Hesong Han

Project Scientist

University of California at Berkeley

Kai-Yuan Chen

Director, Computational Genomics & Data Science

Scribe Therapeutics

Kiran Musunuru

Professor

University of Pennsylvania

Matteo Gentili

Senior Scientist

nChroma Bio

Max Sellman

Senior Product Manager, Gene Editing

Aldevron

Michael Sherman

Principal

Sherman Health Systems

Nageswara Rao Kollu

Senior Director

Apellis Pharmaceuticals

Priya S. Chockalingam

Vice President, Head of Clinical Bioanalytics and Translational Sciences

Beam Therapeutics

Ralf Schmid

Associate Director, Preclinical Research

Ralf Schmid Consulting

Tetsuya Yamagata

Scientific Advisory, Chief Security Officer

Modalis Therapeutics

TJ Cradick

CSO, Principal

Gene Editing Frontiers

Yi Yu

Senior Director, Platform Technologies

nChroma Bio

Yonatan Lipsitz

CEO

Lilium Therapeutics

2025 Program
Register Interest